DarioHealth Corp. (DRIO) Form 8-K — Aug 21, 2026
DarioHealth Corp. disclosed that President and Chief Commercial Officer Steven Nelson will cease serving as an officer effective September 1, 2026, with his employment terminating September 30, 2026, under a separation agreement dated August 20, 2026. The exit follows a medical leave of absence that was extended for an indefinite period on July 10, 2026. Nelson will receive earned wages and accrued vacation, continued health coverage through September, and up to three months of COBRA reimbursement at $2,600 per month, while all outstanding unvested equity awards expire upon termination.
Key figures
- Non Compete Period
- 6 months
- Non Solicit Period
- 12 months
- Consulting Term End
- December 31, 2027
- Officer Cessation Date
- September 1, 2026
- Cobra Reimbursement Months
- 3
- Employment Termination Date
- September 30, 2026
- Consulting Restricted Shares
- 30000
- Cobra Monthly Reimbursement Usd
- 2600
- Immediate Vest Shares If Company Terminates
- 15000
Price after filing
Close on the filing date to close N calendar days later (from $7.17). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.